MP
TDOC icon

Mangrove Partners’s Teladoc Health TDOC Stock Holding History

Mangrove Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-104,420
Closed -$569K – 576
2026
Q1 		$569K Buy
+104,420
New +$586K 0.05% 167
2025
Q3 		– Sell
-94,834
Closed -$826K – 238
2025
Q2 		$826K Buy
+94,834
New +$687K 0.09% 85
2016
Q1 		– Sell
-159,900
Closed -$2.87M – 43
2015
Q4 		$2.87M Hold
159,900
– – 0.71% 31
2015
Q3 		$3.56M Buy
+159,900
New +$4.32M 0.82% 33

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Mangrove Partners's TDOC Position: Q2 2026 in Review

Mangrove Partners sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 104,420 shares — an estimated $569K sold.

Mangrove Partners first reported a position in TDOC in Q3 2015 and held it in 4 quarters. The position peaked at $3.56M in Q3 2015. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Mangrove Partners reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Mangrove Partners sold 104,420 Teladoc Health shares in Q2 2026, an estimated $569K.
  • Mangrove Partners first reported a position in Teladoc Health in Q3 2015 and held it in 4 quarters.
  • Mangrove Partners's Teladoc Health position peaked at $3.56M in Q3 2015.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.